Drug search by name

Certolizumab Subcutaneous and Hematologic abnormalities

Result of checking the interaction of drug Certolizumab Subcutaneous and disease Hematologic abnormalities for safety when used together.

Check result:

Certolizumab Subcutaneous <> Hematologic abnormalities

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Cases of leukopenia, neutropenia, thrombocytopenia, and pancytopenia, some with a fatal outcome, have been reported in patients treated with TNF blocking agents. Caution should be exercised when treating patients who have ongoing or a history of significant hematologic abnormalities. Discontinuation of therapy should be considered in patients with confirmed significant hematologic abnormalities.

Certolizumab Subcutaneous

Generic Name: certolizumab

Brand Name: Cimzia, Cimzia Starter

Synonyms: Certolizumab, Certolizumab Pegol

What is Certolizumab Subcutaneous?